Evaluative research in interventional cardiology has focused on clinical and technical outcomes. Inclusion of economic data can enhance evaluative research by quantifying the relative economic burden incurred by different therapies. When combined with clinical outcomes, cost data can provide a measure of value (e.g., marginal cost-effectiveness). In some select situations, cost data can also be used as surrogates for complexity of care and morbidity. In this narrative review, we aim to provide a framework for the application of cost data in clinical trials and observational research, detailing how to incorporate this kind of data into interventional cardiology research.
|Number of pages||9|
|Journal||Catheterization and Cardiovascular Interventions|
|State||Published - Jan 1 2023|
- CEPO, comparative effectiveness/patient centered outcomes research
- ECO, economica/cost-effectiveness
- HCO, healthcare outcomes